Want to see AU:SKN full AI Analyst Report?
Top Page
Skin Elements Limited
(Sydney:SKN)
Select Model
Select Model
Rating:41Neutral
Price Target:
AU$0.01
â–²(175.00% Upside)
Action:Reiterated
Date:08/30/26
The score is primarily constrained by weak financial performance—sharp revenue decline, severe ongoing losses, and a return to negative operating cash flow in 2026. Valuation inputs are also not supportive due to a negative P/E and no dividend yield data. Technical analysis cannot be meaningfully assessed because key indicators were not provided, so it does not offset the fundamental risk.
Positive Factors
Strong Gross Margin
Sustained gross margins in the mid-80% range indicate attractive product-level economics and potential pricing or product differentiation. If revenue stabilises and operating costs are controlled, this margin base could support future earnings recovery.
Negative Factors
Sharp Revenue Contraction
A substantial revenue decline undermines operating leverage and limits the company’s ability to absorb fixed costs. Unless product demand and distribution improve, shrinking sales could keep the business subscale and delay any path to sustainable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Gross Margin
Sustained gross margins in the mid-80% range indicate attractive product-level economics and potential pricing or product differentiation. If revenue stabilises and operating costs are controlled, this margin base could support future earnings recovery.
Read all positive factors
Skin Elements Limited (SKN) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$12.13M
Dividend YieldN/A
Average Volume (3M)N/A
Price to Earnings (P/E)―
Beta (1Y)1.95
Revenue Growth-50.64%
EPS Growth-72.00%
CountryAU
Employees5
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding3,491,334,200
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio-0.23
Price to Book (P/B)12.40
Price to Sales (P/S)46.65
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Skin Elements Limited Business Overview & Revenue Model
Company Description
Headquartered in West Perth, Australia, Skin Elements Limited is a natural skincare enterprise established in 2015. The company specializes in the development, manufacturing, distribution, and retail of natural, organic, health, and wellness produ...
How the Company Makes Money
null...
Skin Elements Limited Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
34
Negative
Cash Flow
15
Very Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 231.95K | 469.96K | 416.20K | 194.13K | 1.41M |
| Gross Profit | 198.78K | 406.29K | 361.87K | -204.55K | 742.98K |
| EBITDA | -2.35M | -1.63M | -2.08M | -12.08M | -2.15M |
| Net Income | -5.28M | -1.73M | -2.16M | -11.42M | -1.58M |
Balance Sheet | |||||
| Total Assets | 1.32M | 720.21K | 1.44M | 1.69M | 11.10M |
| Cash, Cash Equivalents and Short-Term Investments | 839.50K | 59.65K | 115.07K | 358.43K | 748.05K |
| Total Debt | 302.91K | 444.39K | 731.73K | 17.75K | 24.53K |
| Total Liabilities | 445.61K | 2.66M | 3.08M | 1.08M | 1.05M |
| Stockholders Equity | 872.51K | -1.94M | -1.63M | 604.80K | 10.05M |
Cash Flow | |||||
| Free Cash Flow | 0.00 | 233.85K | -279.38K | -1.84M | -1.50M |
| Operating Cash Flow | -2.63M | 233.85K | -279.38K | -1.84M | -1.50M |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 3.41M | -289.27K | 36.02K | 1.45M | 1.96M |
Skin Elements Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
46 Neutral | AU$19.09M | -12.00 | -50.40% | 2.08% | 28.77% | 60.40% | |
46 Neutral | AU$13.33M | -1.79 | -88.51% | ― | 11.96% | -81.99% | |
44 Neutral | AU$5.64M | -2.81 | -49.07% | ― | -33.53% | 42.98% | |
43 Neutral | AU$16.55M | -0.79 | -33.14% | 4.92% | -14.87% | -35.60% | |
41 Neutral | AU$12.13M | -0.67 | -430.23% | ― | -50.64% | -72.00% | |
39 Underperform | AU$15.82M | -4.94 | 1795.70% | ― | 0.72% | -486.96% |
* Consumer Defensive Sector Average
AU:SKN
Skin Elements Limited
―
―
―
AU:MCP
Mcpherson'S Limited
0.12
-0.15
-56.60%
AU:EVE
EVE Health Group Limited
0.02
-0.01
-46.67%
AU:ZNO
Zoono Group Limited
0.05
0.02
50.00%
AU:NUC
Nuchev Pty Ltd
0.09
-0.06
-43.33%
AU:HCT
Holista Colltech Limited
0.04
-0.06
-59.05%
Skin Elements Limited Corporate Events
Skin Elements lodges 2026 preliminary final report and updates corporate details
Aug 28, 2026
Skin Elements Limited has released its Appendix 4E preliminary final report and annual report for the year ended 30 June 2026. The filing formalises its governance and reporting framework, confirming the current board, key executives, auditors and...
Skin Elements Secures Farmlands Deal and New Funding Amid Board Overhaul
Jul 30, 2026
Skin Elements Limited reported a pivotal quarter marked by the signing of an exclusive distribution deal with Farmlands Co-Operative Society in New Zealand for its ECO-Nurture horticultural bio-stimulant. The agreement, following multi-season tria...
Skin Elements seeks ASX quotation for 25 million new shares
Jul 9, 2026
Skin Elements Limited has applied for the quotation of 25,000,000 ordinary fully paid shares on the ASX, with an issue date of July 8, 2026. The move formalises the listing of these new securities, supporting the company’s capital structure ...
Skin Elements Secures NZ$600,000 Farmlands Deal for ECO-Nurture in Kiwifruit Sector
Jul 8, 2026
Skin Elements has signed an exclusive distribution agreement with New Zealand’s largest farmer-owned rural co-operative, Farmlands, for its ECO-Nurture horticultural bio-stimulant. Farmlands has placed an initial NZ$600,000 order for 4,000 l...
Skin Elements Requests Trading Halt Ahead of Major Distribution Deal
Jul 6, 2026
Skin Elements Limited has requested a trading halt in its securities on the ASX, effective immediately, as it prepares to announce a material distribution agreement. The halt will remain in place until the announcement is released or normal tradin...
Skin Elements Appoints New Director With No Current Shareholding
Jun 26, 2026
Skin Elements Limited has appointed Frank Knezovic as a director effective 23 June 2026, according to an initial director’s interest notice lodged with the ASX. At the time of his appointment, Knezovic holds no relevant interests in the comp...
Skin Elements files final interest notice as director Stuart Usher exits board
Jun 26, 2026
Skin Elements has announced that director Stuart Usher has ceased to serve on the company’s board as of 22 June 2026, triggering a final director’s interest notice under ASX listing rules. The filing confirms that Mr Usher held no secu...
Skin Elements plans placement of up to 25 million new shares
Jun 25, 2026
Skin Elements Limited has notified the ASX of a proposed placement of up to 25 million new ordinary fully paid shares. The new securities, to be issued under ASX Listing Rule procedures, are scheduled for issue on 30 June 2026, expanding the compa...
Skin Elements plans major share issue to raise new capital
Jun 25, 2026
Skin Elements Limited has notified the ASX of a proposed issue of up to 318 million new fully paid ordinary shares under a placement or similar capital raising structure. The securities, expected to be issued on 16 July 2026, represent a substanti...
Skin Elements raises A$900,000 and reshapes board and investor relations
Jun 25, 2026
Skin Elements Limited has secured A$900,000 through a discounted share placement to sophisticated and professional investors, issuing 300 million new shares to bolster its balance sheet and working capital. The funds will be directed towards advan...
Skin Elements Requests Trading Halt Ahead of Capital Raising
Jun 25, 2026
Skin Elements Limited has requested a trading halt in its securities on the ASX as it prepares to announce a capital raising, with the halt effective immediately and set to last until either the announcement is released or normal trading resumes o...
Skin Elements refreshes board as shareholders approve new directors at EGM
Jun 23, 2026
Skin Elements Limited reported the outcomes of its Extraordinary General Meeting held on 23 June 2026, in which the chair directed all undirected proxies in favour of all resolutions. Three resolutions seeking the removal of directors were withdra...
Skin Elements Reshapes Board Following Shareholder-Driven Governance Push
Jun 22, 2026
Skin Elements Limited, an ASX-listed natural biotechnology company, develops plant-based and organic formulations for global consumer and industrial markets, including disinfectants, bio-stimulants, sunscreens and therapeutic skincare products. It...
Skin Elements seeks ASX quotation for 95 million new shares
Jun 5, 2026
Skin Elements Limited has applied for the quotation of 95,000,000 new ordinary fully paid shares on the Australian Securities Exchange, with an issue date of 4 June 2026. The new securities arise from the exercise or conversion of existing options...
Skin Elements director Peter Malone steps down but retains major indirect stake
Jun 5, 2026
Skin Elements has announced that director Peter Malone ceased to be a director on 2 June 2026, with a final disclosure of his interests in the company’s securities. The filing shows Malone held no shares directly, but maintained substantial ...
Skin Elements director’s options lapse with no change to shareholding
Jun 5, 2026
Skin Elements Limited has disclosed a change in director Filippo (Phil) Giglia’s interests following the expiry of certain options. Giglia holds his interests indirectly through Colosseum Securities Pty Ltd, where he is sole director and a b...
Skin Elements Issues 95 Million New Ordinary Shares After Option Conversions
Jun 4, 2026
Skin Elements Limited has notified the market that 95,000,000 ordinary fully paid shares are being issued following the exercise or conversion of previously unquoted securities. The substantial new share issuance will expand the company’s ca...
Skin Elements EGM Yields Split Vote on Board Removals and Governance Changes
Jun 2, 2026
Skin Elements Limited has announced the results of its Extraordinary General Meeting held on 2 June 2026, where shareholders voted on several board changes and a constitutional amendment. Resolutions to remove directors Filippo (Phil) Leone Giglia...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.